SUPERNUS PHARMACEUTICALS INC (SUPN) Stock News

NASDAQ:SUPN - Nasdaq - US8684591089 - Common Stock - Currency: USD

35.505 +0.41 (+1.15%)

After market: 35.505 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SUPN Latest News, Press Relases and Analysis

All

Press Releases

16 days ago - By: Chartmill

News Image

SUPERNUS PHARMACEUTICALS INC (NASDAQ:SUPN) - An Undervalued Stock With Strong Fundamentals

3 days ago - By: Supernus Pharmaceuticals, Inc. - Mentions: SAGE

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics

3 days ago - By: Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics

6 days ago - By: Supernus Pharmaceuticals, Inc. - Mentions: SAGE

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

6 days ago - By: Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

11 days ago - By: Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025

11 days ago - By: Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025

a month ago - By: Brodsky & Smith LLC - Mentions: VERV SAGE CTLP NYSE ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

2 months ago - By: Yahoo Finance - Mentions: BIIB SAGE

H.C. Wainwright sees potential competition for Sage from Biogen

2 months ago - By: Benzinga - Mentions: SAGE

These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News

2 months ago - By: Brodsky & Smith LLC - Mentions: VERV SAGE CTLP SOAR ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

2 months ago - By: Yahoo Finance - Mentions: ROKU RY RY.CA AMZN ...

Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus

2 months ago - By: Rowley Law PLLC - Mentions: SAGE

News Image

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.

2 months ago - By: Yahoo Finance - Mentions: AGEN HON ITGR TTEK ...

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

2 months ago - By: Yahoo Finance - Mentions: CRCL SF HNGE ATAT ...

How to get a $40,000 personal loan

2 months ago - By: Yahoo Finance - Mentions: SAGE BIIB

Supernus makes depression drug play with $795m Sage buyout

2 months ago - By: Benzinga - Mentions: BIIB SAGE

Supernus Pharma Acquires Maker Of Postpartum Depression Drug Zurzuvae In $795 Million Deal

2 months ago - By: Investor's Business Daily - Mentions: SAGE BIIB

Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million

2 months ago - By: Yahoo Finance - Mentions: SAGE BIIB

Sage, following Setbacks, to sell to Supernus for $561M

2 months ago - By: Supernus Pharmaceuticals, Inc.; Sage Therapeutics, Inc. - Mentions: SAGE

Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio

2 months ago - By: Supernus Pharmaceuticals, Inc.; Sage Therapeutics, Inc.

Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio

2 months ago - By: Supernus Pharmaceuticals, Inc.

Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals

2 months ago - By: Supernus Pharmaceuticals, Inc.

Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals

2 months ago - By: Supernus Pharmaceuticals, Inc.

Supernus Announces Paragraph IV ANDA Filings for Qelbree®

2 months ago - By: Supernus Pharmaceuticals, Inc.

Supernus to Participate in the 2025 Jefferies Global Healthcare Conference

2 months ago - By: Supernus Pharmaceuticals, Inc.

Supernus to Participate in the 2025 Jefferies Global Healthcare Conference

2 months ago - By: Supernus Pharmaceuticals, Inc.

Supernus Announces Paragraph IV ANDA Filings for Qelbree®

2 months ago - By: Supernus Pharmaceuticals, Inc.

Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being ‘Ms. Represented’ in First-of-its-Kind Campaign with Supernus Pharmaceuticals

2 months ago - By: Supernus Pharmaceuticals, Inc.

Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being ‘Ms. Represented’ in First-of-its-Kind Campaign with Supernus Pharmaceuticals